Loading company…
REMED BrainStim develops transcranial magnetic stimulation devices and therapy management tools.
Founded in 2020 in Gyeonggi-do, South Korea, REMED BrainStim develops noninvasive transcranial magnetic stimulation devices. Its products address concentration, memory, depression, and other applications, while NextQure provides a platform for managing ongoing patient therapy. In May 2023, the company raised KRW 3.5 billion in seed funding from COMES Investment and SL Investment to promote home use and develop products for additional conditions.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in